Patel Sanj K's Form 4 filing
Kiniksa Pharmaceuticals International, plc (KNSA) · filed May 28, 2025
- Accession no.
- 0001415889-25-014744
- Filed
- May 28, 2025
- Trade date
- May 23-28, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.35M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel Sanj KCIK 0001532218 | Director, Officer (CHAIRMAN & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +4,837 | $1.59 | +$7,690.83 | 101,511 | Direct | |
| May 23, 2025 | Class A Ordinary Share | SSaleDisposed | −4,837 | $27.00 | −$130,599 | 96,674 | Direct | |
| May 27, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +19,317 | $1.59 | +$30,714.03 | 115,991 | Direct | |
| May 27, 2025 | Class A Ordinary Share | SSaleDisposed | −19,317 | $27.01 | −$521,752.17 | 96,674 | Direct | |
| May 28, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +62,116 | $1.59 | +$98,764.44 | 158,790 | Direct | |
| May 28, 2025 | Class A Ordinary Share | SSaleDisposed | −62,116 | $27.33 | −$1,697,630.28 | 96,674 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −4,837 | $0.00 | $0 | 81,433 | Direct | |
| May 27, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −19,317 | $0.00 | $0 | 62,116 | Direct | |
| May 28, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −62,116 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.